Cannabis Law Report

NOVEMBER 9, 2021

Today marks a major step towards Akanda’s establishment as an international medical cannabis company helping patients around the world lead better lives,” commented Tej Virk, CEO and Director of Akanda. “At Akanda also issued a secured convertible debenture (the “Debenture”) to Halo in the principal amount of US$6.6

Collective 52

Collective Supply Chain Seed-To-Sale Events 52

Cannabis Law Report

JULY 2, 2021

Ohio is a key state, currently a top-five market for Columbia Care, with year-to-date state sales up more than 110 percent year-over-year and annualized runrate sales of more than $370 million for 2021. We are honored to directly serve the medical cannabis community in Ohio, which has grown to more than 200,000 registered patients.”.

Dispensary 66

Dispensary Seed-To-Sale Research and Development Cultivation 66

Cannabis Law Report

FEBRUARY 3, 2022

This non-dilutive financing provides Columbia Care with additional flexibility to continue executing on our strategic growth initiatives, especially in markets like New Jersey, New York and Virginia, where we are serving a growing number of medical patients and preparing for adult use on the horizon. About Columbia Care.

Seed-To-Sale 52

Seed-To-Sale Media Cultivation Events 52

Cannabis Law Report

FEBRUARY 17, 2022

WORCESTER – The Cannabis Control Commission (Commission) is alerting patients and consumers to its quarantine order (Order), issued October 18, 2021, mandating that ACK Natural, LLC, a colocated medical- and adult-use licensee, recall all products with unverifiable mycotoxin test results sold to its consumers and patients.

Marijuana 52

Marijuana Seed-To-Sale Safety Patients 52

Project CBD

FEBRUARY 28, 2023

HerbalGram, the acclaimed quarterly journal of the American Botanical Council, recently published its 2021 “Herb Market Report,” which included data on sales of CBD as an herbal ingredient in mainstream and natural retail channels in the United States. E-commerce sales of CBD in the U.S. increase in annual sales.

CBD 144

CBD Seed-To-Sale Food Access 144

Cannabis Law Report

JULY 23, 2019

Freia (www.freiafarmaceutici.it) was founded in 2009 and is presently the only company in Italy and one of few in Europe, to have created and are marketing hemp based pharmaceutical products approved by the Italian Ministry of Health and licensed for sale throughout the EU. This EU pharmaceutical entity is an optimal addition to LGC.

Pharmaceutical 45

Pharmaceutical Seed-To-Sale Compliance Compliance 45

Cannabis Law Report

DECEMBER 17, 2019

Our Wall St contact tells us this report is a big topic of discussion on the street today. Published by Siegfried Eggert of Geoinvesting the report alleges a list of wrongdoings so egregious that it’s impossible to know where to start. CEO Kim Rivers and companies affiliated with her are mentioned in FBI subpoenas.

Seed-To-Sale 59

Seed-To-Sale Events Research and Development Business 59

Cannabis Law Report

NOVEMBER 1, 2021

The Transaction is scheduled to close on or about November 15, 2021 , and subject to customary closing conditions and covenants. TGOD to acquire Galaxie Brands Corporation. Acquisition significantly expands and diversifies TGOD’s product portfolio through: Galaxie’s exclusive joint venture in Canada , with a major U.S.

Research and Development 52

Research and Development Edibles Vaping Seed-To-Sale 52

Cannabis Law Report

JUNE 18, 2019

She stated, “As legalization of cannabis expands across the world, we believe it is imperative that businesses, patients, consumers, and governments have the tracking and compliance technology they need to make informed decisions and comply with applicable regulations. Here’s the release in full as related via Nasdaq.

Compliance 40

Compliance Compliance Seed-To-Sale Supply Chain 40

Cannabis Law Report

DECEMBER 2, 2021

InterCure will leverage its licensed international supply chain to serve the growing communities of medical cannabis patients in Europe. Cookies Partners With Leading Global Cannabis Company InterCure to Open Retail Locations in Austria and the U.K. in Early 2022. Learn more at cookies.co. About InterCure and Canndoc.

Supply Chain 52

Supply Chain Seed-To-Sale Media Events 52

Cannabis Law Report

SEPTEMBER 1, 2019

The long-promised, glittering ambitions of a large-scale medicinal cannabis industry in South Australia are about to be tested, with plans to create more than 1000 jobs at a major new manufacturing facility in Adelaide. reports In Daily and independent news source based in the city. Fitzsimons seized the opportunity.

Clinical Trials 53

Clinical Trials Research and Development Medicine Cultivation 53

The Cannigma

FEBRUARY 16, 2022

Listen & Subscribe: In light of Black History Month, we feel it is important and relevant to talk about how minorities in the United States and around the world have been disproportionately affected by drug policy and the war on drugs. Tuning in, you’ll hear more about what these trichomes are and why they’re important. CP: It’s a celebration.

Trichome 73

Trichome Wellness and Beauty Cannabinoids Cannabis 73

Cannabis Law Report

NOVEMBER 17, 2021

This financing provides vital capital to accelerate our plans to build one of the leading international medical cannabis companies with a unique seed-to-patient business model,” said Tej Virk, CEO and Director of Akanda. “In And we’re establishing a world class team. About Akanda Corp.

Seed-To-Sale 52

Seed-To-Sale Supply Chain Cultivation Events 52

Cannabis Law Report

NOVEMBER 9, 2021

“I am thrilled to be joining an organization aiming to improve the quality of patient lives and to create a better future for the communities in which it operates,” commented Dr. Akkar-Schenkl. She will work closely with Akanda’s EU GMP processing and distribution partner Cantourage GmbH, based in Germany. . About Akanda Corp.

Pharmaceutical 52

Pharmaceutical Seed-To-Sale Supply Chain Events 52

Cannabis Law Report

JUNE 4, 2021

Our proprietary ranking system takes into account: Social reach (social media, blogs, podcasts, publications, etc.). They write… As the global COVID-19 pandemic drags on around the world, the damaging effects to mental health are becoming more and more apparent. there has never been a better time for new treatment options.

Research and Development 51

Research and Development Medicine Treatment Pharmaceutical 51